User profiles for C. Fuchs

Christian Fuchs

- Verified email at upb.de - Cited by 32151

Christopher A. Fuchs

- Verified email at umb.edu - Cited by 18307

Gastric carcinoma

CS Fuchs, RJ Mayer - New England Journal of Medicine, 1995 - Mass Medical Soc
Despite a marked decline in the incidence of gastric carcinoma in many industrialized nations,
cancer of the stomach remains the second most common cause of cancer-related deaths …

Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease

…, GG Konijeti, LM Higuchi, P de Silva, CS Fuchs… - Gut, 2014 - gut.bmj.com
Introduction Dietary fats influence intestinal inflammation and regulate mucosal immunity.
Data on the association between dietary fat and risk of Crohn's disease (CD) and ulcerative …

Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

…, E Giovannucci, G Dranoff, CS Fuchs… - The Journal of …, 2010 - Wiley Online Library
The abundance of tumour‐infiltrating T‐cells has been associated with microsatellite instability
(MSI) and a favourable prognosis in colorectal cancer. However, numerous molecular …

Unconditional quantum teleportation

A Furusawa, JL Sørensen, SL Braunstein, CA Fuchs… - science, 1998 - science.org
… So long as Alice and Bob can communicate only over a classical channel, we have shown
that for g = 1, σ W > σ in + 2, so that σ W c = 3 heralds the boundary between quantum and …

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised …

CS Fuchs, J Tomasek, CJ Yong, F Dumitru… - The Lancet, 2014 - thelancet.com
… Charles S Fuchs … growth factor receptor, insulin-like growth factor, human epidermal
growth factor receptor-2, c-MET), MEK inhibitors, and drugs targeting the Hedgehog pathway. …

[PDF][PDF] A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal …

…, DJ Sargent, RF Morton, CS Fuchs… - Journal of Clinical …, 2004 - hayaobio.net
Purpose Three agents with differing mechanisms of action are available for treatment of
advanced colorectal cancer: fluorouracil, irinotecan, and oxaliplatin. In this study, we compared …

[HTML][HTML] Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment

…, GL Hold, EM El-Omar, D Brenner, CS Fuchs… - Cell host & …, 2013 - cell.com
Increasing evidence links the gut microbiota with colorectal cancer. Metagenomic analyses
indicate that symbiotic Fusobacterium spp. are associated with human colorectal carcinoma, …

[HTML][HTML] Postmenopausal hormone therapy and mortality

…, JAE Manson, M Joffe, B Rosner, C Fuchs… - … England Journal of …, 1997 - Mass Medical Soc
Background Postmenopausal hormone therapy has both benefits and hazards, including
decreased risks of osteoporosis and cardiovascular disease and an increased risk of breast …

[BOOK][B] Internet and society: Social theory in the information age

C Fuchs - 2007 - taylorfrancis.com
… Christian Fuchs contends that some arguments of the Marxist tradition are still valid while
some are not. He shows that by a proper merger of both lines of thought a grand social theory …

Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical …

CS Fuchs, T Doi, RW Jang, K Muro, T Satoh… - JAMA …, 2018 - jamanetwork.com
Importance Therapeutic options are needed for patients with advanced gastric cancer whose
disease has progressed after 2 or more lines of therapy. Objective To evaluate the safety …